Objective: A naturally-occurring mutation in cardiac calsequestrin (CASQ2) at amino acid 307 was discovered in a highly inbred family and hypothesized to cause Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The goal of this study was to establish a causal link between CASQ2 D307H and the CPVT phenotype using an in vivo model. Methods and results: Cardiac-specific expression of the CASQ2 D307H transgene was achieved using the α-MHC promoter. Multiple transgenic (TG) mouse lines expressing CASQ2 D307H from 2-to 6-fold possess structurally normal hearts without any sign of hypertrophy. The hearts displayed normal ventricular function. Myocytes isolated from TG mice had diminished I Ca -induced Ca 2+ transient amplitude and duration, as well as increased Ca 2+ spark frequency. These myocytes, when exposed to isoproterenol and caffeine, displayed disturbances in their rhythmic Ca 2+ oscillations and membrane potential, and delayed afterdepolarizations. ECG monitoring revealed that TG mice challenged with isoproterenol and caffeine developed complex ventricular arrhythmias, including non-sustained polymorphic ventricular tachycardia. Conclusions: The findings of the present study demonstrate that expression of mutant CASQ2 D307H in the mouse heart results in abnormal myocyte Ca 2+ handling and predisposes to complex ventricular arrhythmias similar to the CPVT phenotype observed in human patients.
Introduction

CASQ2 is the most abundant Ca
2+ buffering protein present in the lumen of the cardiac sarcoplasmic reticulum (SR). It allows calcium to be stored at total concentrations of up to 20 mM, while the free concentration remains ∼ 1 mM [1] [2] [3] [4] . It binds calcium with high capacity (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) Ca 2+ /CASQ2) and moderate affinity (k d ∼ 1 mM) [1, [3] [4] [5] . Increasingly, it has become apparent that CASQ2 might also play an important role in regulating the SR Ca 2+ release [6, 7] . Studies have suggested that CASQ2 can interact functionally with the cardiac ryanodine receptor (RyR2) in vitro, either by binding with the RyR2 directly or through its interactions with junctin and triadin [8] [9] [10] [11] . It is hypothesized that this interaction allows CASQ2 to be localized to the terminal cisternae of the junctional SR (jSR) [8, 10, 12, 13] . Also, it was proposed that through interaction with triadin, CASQ2 might be able to communicate with the RyR2 [6, 14] . However, the nature of this interaction and its exact role in Ca 2+ release remain to be understood.
The importance of CASQ2 is highlighted by the fact that mutations in the CASQ2 gene have been recently linked to ventricular arrhythmias and sudden cardiac death [15] [16] [17] . In particular, a naturally-occurring mutation in cardiac CASQ2 at amino acid 307 (CASQ2 D307H ) was discovered in seven Bedouin families [18, 19] , as a potential cause for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) [19] . CPVT is a disease that is characterized by adrenergically-mediated ventricular tachycardia that can rapidly progress into ventricular fibrillation and sudden cardiac death [18] . The characteristic symptoms are recurrent syncope, seizures, or sudden death triggered by exercise or emotional stress, both of which raise the levels of catecholamines [18] .
Sequencing of DNA obtained from CPVT patients showed that CASQ2 exon 9 had a G → C substitution at nucleotide 1038 [19] . This substitution resulted in a change from an aspartate residue to a histidine at position 307 in CASQ2 [19] . This aspartate residue is invariant both in vertebrate and invertebrate CASQ [19] sparks) [20] . In addition, the rhythmicity of the Ca 2+ transients was disrupted in these myocytes upon catecholamine stimulation.
In the present study, we wished to determine the effect of CASQ2 D307H on heart function by chronically expressing this mutant protein in vivo. This was accomplished by generating TG mouse lines that express CASQ2 D307H in the heart. Transgenic expression of mutant protein does not lead to cardiac hypertrophy. Cardiomyocytes isolated from the TG mice displayed in vitro arrhythmias that are consistent with the CPVT phenotype. Most importantly, complex ventricular arrhythmias, including non-sustained ventricular tachycardia, are triggered in the hearts of TG mice when challenged with isoproterenol and caffeine. Our findings in the TG mouse suggest that CASQ2 D307H mutation can contribute to the CPVT phenotype in humans.
Materials and methods
Generation of TG mice expressing the CASQ2
D307H mutant protein
The D307H mutation was introduced into the rat CASQ2 open reading frame, using PCR methodology. Once the D307 → H mutation was confirmed by DNA sequencing, the coding region of the mutant protein was sub-cloned into a vector containing the α-MHC promoter as described previously [21] [22] [23] . TG mice (FVB/N) expressing mutant CASQ2 D307H were generated by the TG core facility. This investigation conforms to the guide for Care and Use of laboratory animals published by the US national Institutes of Health (NIH publication # 85-23, revised 1996).
Western blotting analyses
Western blotting was performed following standard protocols [24] .
Isolation of mouse myocytes and electrophysiological recordings
Myocytes were isolated using established protocols [25] . Transmembrane ionic currents were measured using wholecell patch-clamp recordings, as described previously [26] , with Axopatch 200B amplifier (Axon Instruments, USA) and pClamp-9 software.
Confocal Ca 2+ measurements
Intracellular Ca 2+ imaging was performed by using an Olympus Fluoview 1000 laser scanning confocal microscope equipped with an Olympus 60 Ч 1.4NA oil objective. Fluo-3 was excited by the 488-nm line of an argon-ion laser, and the fluorescence was acquired at wavelengths N510 nm in the line-scan mode of the confocal system at the rate of 2 ms per scan. Ca 2+ spark parameters were quantified with a detection/analysis computer algorithm [26] .
ECG monitoring and induction of arrhythmia
ECG recordings were obtained from mice as previously described [27] [28] [29] . Mice over-expressing CSQ D307H (n = 8) and their wild-type littermates (n = 8) were anesthetized with isoflurane (1-1.5%) at minimum effective concentrations, and placed on a heating pad (Braintree Scientific, Inc.) to maintain normothermia. ECGs were recorded using a physiologic data acquisition system (MP 100, Biopac Systems) with a sampling rate of 2 kHz for 84 ± 17 min. After baseline recording (10 min), 5 pairs of mice (5 WT and 5 TG: 2 pairs each from 2-and 4-fold lines, and 1 pair from 6-fold line) received 4 doses of isoproterenol (2 mg/kg IP) in 10-20 min intervals, the first 2 of which were combined with caffeine (120 mg/kg IP [30, 31] ). To ensure that the observed arrhythmias were adrenergically mediated, another group of mice (3 pairs from 2-fold line) received incremental doses of isoproterenol alone every 10 min (cumulative dose of 8.75 ± 0.02 mg/kg IP). Both TG and age-matched WT littermates were tested the same day using the same drug protocol. ) and WT hearts. (A) 5-10 μg of whole heart homogenates (2-and 6-fold CASQ2 D307H ) were separated on 10% SDS-PAGE gels and probed with antibodies against CASQ2, SERCA 2a, triadin, α-actin and α-actinin. (B) 4-8 μg (10-30 μg for RyR2) of whole heart homogenates (6-fold CASQ2 D307H ) were separated on SDS-PAGE gels and probed with antibodies against RyR2 (4-20% gradient gel), SERCA 2a (10% gel), Phospholamban (PLB; 15% gel), L-type Calcium Channel (DHPR 2α; 10% gel) and Na + /Ca 2+ Exchanger (NCX1; 10% gel). The 120-kDa full length NCX1 protein is shown [44] . (C) CASQ2 Immunofluorescence in TG and WT myocytes. Mice ventricular cardiomyocytes from WT littermates and TG (6-fold CASQ2 D307H ) were immunostained with mouse anti-α-actinin (1:500) or rabbit anti-calsequestrin (1:200), followed by Alexa 488-conjugated goat anti-mouse (1:300) and Cy™3-conjugated Donkey anti-rabbit (1:300 dilution) antibodies.
Statistical analysis
Cross tabulations with chi-square and yale correction factor or z-test were used as appropriate for categorical variables using a statistical software package (Sigmastat 2.03, Jandel Scientific).
Results
Generation and characterization of TG mice expressing CASQ2 D307H
Cardiac-specific expression of the CASQ2 D307H transgene was achieved using the α-MHC promoter [21] [22] [23] . Out of five positive TG lines containing the transgene, three TG lines (F8, F17, and F21) were propagated for further characterization. Three-to six-month-old mice were used for the studies, except as indicated.
The level of CASQ2 D307H protein expression in the three TG lines was determined by western blotting using an antibody specific for cardiac CASQ2 (Fig. 1A) . Quantification of CASQ2 bands showed that the CASQ2 D307H protein is expressed 2-, 4-and 6-fold in TG lines F21, F8 and F17, respectively ( Fig. 1A and data not shown). These data confirmed that we obtained multiple TG lines with graded expression of the CASQ2 D307H protein, thus allowing us to compare the effect of expressing different amounts of mutant protein. To determine whether expression of CASQ2 D307H protein induced alterations in other SR proteins, we determined the levels of RyR2, L-type Calcium Channel (DHPR 2α), Na + /Ca 2+ Exchanger (NCX1), triadin, SERCA 2a and phospholamban (PLB) in the 4-and 6-fold lines ( Fig. 1B and data not shown). Quantification and correction for loading variations indicated that there were no significant changes in the expression levels of these proteins. Therefore 2-to 6-fold expression of CASQ2 D307H does not alter the expression levels of related SR Ca 2+ transport proteins. For most of the studies described below we compared the 2-fold and 6-fold over-expressors.
TG cardiac myocytes show subtle structural changes
To determine whether the mutant CASQ2 D307H was being properly localized to the junctional SR, confocal and electron microscopy (EM) were performed. Imaging of the stained cells revealed the expected patterns of fluorescence for CASQ2 and α-actinin (Fig. 1C) . The CASQ2 staining co-localized with the α-actinin staining, consistent with the fact that the Z-line (α-actinin) and junctional SR (CASQ2) are in close proximity to one another. The only difference between the TG and WT staining pattern was that the intensity of CASQ2 staining appeared brighter in the TG myocytes, which is consistent with the over-expression of CASQ2 D307H in the 6-fold line. The ultrastructure of myocytes expressing CASQ2 D307H was very similar to that of WT littermate cells but subtle changes were observed. We observed variations in the size and internal configuration of the jSR cisternae associated with the transverse tubules. In WT myocardium, the jSR is typically in the form of flat cisternae with a dense content, due to calsequestrin, that is condensed into periodic densities ( Fig. 2A) . Most of the cisternae in the mutant hearts have the same general structure as WTones ( Fig. 2B and C) . Some however, show a decrease in the dense content, a general loosening of the content disposition and some widening of the cisternae (Fig. 2E and F) . Some TG myocytes show evidence for a disturbance of T tubules. Normally, T tubules run transversely at the Z lines and have occasional longitudinal branches. In thin sections, each intermyofibrillar space has either none or a single T tubule profile. Some myocytes from CASQ2 D307H TG hearts show multiple T tubule profiles, indicating a convoluted tubule (data not shown).
TG hearts expressing CASQ2
D307H show normal overall structure and contractility
We also wanted to make sure that expression of mutant CASQ2 D307H does not cause cardiac hypertrophy/pathology that may complicate our analysis. Several lines of evidence suggest that the TG hearts are essentially normal. First, there was no change in the heart weight-to-body weight ratios of TG (4.4 ± 0.7 mg/g) compared to WT (4.3±0.3 mg/g) mice. Second, hearts from TG and WT littermates were subjected to standard histological analysis by staining with hematoxylin/eosin. These hearts appear normal and do not exhibit hypertrophy or fibrosis. Myocyte structure is similar in appearance in all hearts (Fig. 3A) . Third, we examined the expression level of genes that are known markers of hypertrophy: atrial natriuretic factor (ANF), β-myosin heavy chain (β-MHC) and skeletal α-actin by RT-PCR. These genes are typically re-activated under conditions of cardiac hypertrophy, but we did not see activation of these genes in TG hearts (data not shown).
M-mode echocardiography in WT (Fig. 3B , top panel) and TG (lower panel) mice showed normal cardiac chamber and contractility with no evidence of structural abnormalities. There were no differences in the left ventricular end systolic dimension (LV-ESD) and end diastolic dimension (LV-EDD) and fractional shortening (FS) in TG mice compared to their littermate controls (see Table 1 ).
SR Ca 2+ content and release
Calsequestrin is a Ca 2+ storage protein and expression of mutant CASQ2 D307H could affect calcium stores and release properties. Therefore, we studied the calcium handling properties of myocytes isolated from TG and WT hearts. Caffeine applications (10 mM) were used to assess changes in showing normal cardiac chamber size and contractility with no evidence of structural abnormalities. Summary of data are shown in Table 1 . (Fig. 4B-C) .
Ca
2+ sparks, Ca 2+ transients and I Ca
The effects of expressing mutant CASQ2 D307H on I Ca and intracellular [Ca 2+ ] transients in patch-clamped myocytes are illustrated in Fig. 4D -F. There were no apparent changes in the parameters of I Ca in myocytes expressing CASQ2 D307H and cells from WT littermates (Fig. 4F, Table 2 ). The peak amplitude of I Ca was nearly identical for all experimental groups of cells. In addition, the time course of I Ca decay was similar (Table 2) . Thus, expression of CASQ2 D307H did not change the characteristics of the Ca 2+ trigger for Ca 2+ release from the SR. However, Ca 2+ transients from TG mice were smaller and had reduced τ decay compared to WT myocytes ( Fig. 4D-E and Table 2 ). Measurement of spontaneous Ca 2+ sparks in permeabilized myocytes from TG mice and their WT littermates showed a trend toward decreased Ca 2+ spark amplitude and a significant increase in Ca 2+ spark frequency (Supplemental data and Table 3 ).
Ca 2+ cycling in rhythmically paced myocytes
The effects of isoproterenol treatment (1 μmol/L) on periodic Ca 2+ transients in WTand TG myocytes are illustrated in Fig. 5 . To induce arrhythmia in myocytes, we used a modified protocol [30] where the bath solution contains 100 μM of caffeine. The myocytes were stimulated at 1 Hz, and membrane potential (MP) changes were recorded in the current-clamp mode. The exposure of WT myocytes to isoproterenol caused an increase in the amplitude of Ca 2+ transients without any apparent disturbances in periodic Ca 2+ cycling ( Fig. 5A-B ; results are representative of six myocytes). However, in TG myocytes expressing CASQ2 D307H , the amplitude of Ca 2+ current-induced Ca 2+ transients was reduced (Fig. 5A) . The action potential duration between control and TG myocytes was not significantly different (APD 90 is 57 ± 24 for WT and 45 ± 19 for TG animals). Isoproterenol administration in the presence of caffeine (Fig. 5B) , spontaneous release usually originated locally and then propagated through the cell as a regenerative Ca 2+ wave. Importantly, the membrane potential traces showed delayed afterdepolarizations (DADs) and the occasional generation of action potentials at the time of spontaneous Ca 2+ transients. Similar results were obtained in four other myocytes. These results indicate that expression of CASQ2 D307H destabilizes the Ca 2+ release mechanism, leading to spontaneous, premature discharges of SR Ca 2+ stores in myocytes undergoing periodic pacing.
Complex ventricular arrhythmias are triggered in TG hearts by isoproterenol and caffeine
Continuous ECG monitoring prior to drug challenge did not reveal any significant spontaneous ventricular arrhythmias in WT mice. In contrast, CASQ2 D307H mice had more spontaneous supraventricular ectopic beats at baseline than WT mice (cumulative numbers of observations were 378 vs. 8 in TG and WT mice, respectively, P b 0.001).
After challenge with isoproterenol alone or in combination with caffeine, mutant CASQ2 D307H mice developed significantly more supraventricular and junctional ectopic beats compared to WT (cumulative numbers of observations for junctional ectopic beats were 2862 vs. 39 in TG and WT mice, respectively, P b 0.001). CASQ2 D307H mice did not have an increased number of simple ventricular arrhythmias compared to WT (Fig. 6A) . However, after drug challenge, the number of total complex ventricular arrhythmias was increased 4-fold (P b 0.001) in CASQ2 D307H mice compared to WT mice (Fig. 6A) . Furthermore, there was a significant increase (P b 0.05) in the number of CASQ2 D307H mice that developed complex ventricular arrhythmias (Fig. 6B) , including non-sustained ventricular tachycardia, compared to WT mice ( Fig. 6C and D) .
Discussion
CPVT is a potentially devastating condition that can lead to sudden cardiac death even in very young children after physical or emotional stress. CPVT can be caused by mutations in either the ryanodine receptor (RyR2) or the CASQ2 gene [15, 17, 19, [32] [33] [34] [35] . There are several different RyR2 mutations that are linked to CPVT and they are all dominant, while there are fewer known CASQ2 mutations and these are all recessive [15, 17] . In the present study, we chose to introduce increasing amounts of mutant CASQ2 D307H to compete with the endogenous WT CASQ2 protein to determine its effect on Ca 2+ handling and heart function. Since the CASQ2 D307H mutation is recessive, we predicted that low amounts of CASQ2 D307H would not significantly affect heart function, while higher amounts of CASQ2 D307H would out-compete the endogenous WT CASQ2 and lead to ventricular arrhythmias. Our findings show that TG mice did not develop a significant amount of spontaneous ventricular arrhythmias under resting conditions. However, when challenged with catecholamines, the TG hearts developed a much higher level of complex ventricular arrhythmias compared to WT hearts (Fig. 6A) . These complex VEBs included couplets, bigeminy, trigeminy, as well as non-sustained ventricular tachycardia, both monomorphic and polymorphic, consistent with the CPVT phenotype observed in patients in that they are triggered by catecholamines. We observed arrhythmias in all 3 TG lines and did not observe a graded response between lines.
The predisposition to complex ventricular arrhythmias in our TG mice could be due to the D307H mutation itself and/or increased expression of CASQ2 in the heart. Recent studies showed that over-expression of WT mouse CASQ2 (20-fold) and canine CASQ2 (10-fold) in the mouse hearts can cause mild to severe cardiac hypertrophy and result in an increase in SR Ca 2+ storage capacity [36, 37] . Despite an increase in Ca 2+ storage capacity, Ca 2+ release was severely compromised in these mice. These data suggested that excessive amounts of CASQ2 can also lead to abnormally high levels of Ca 2+ storage but reduced Ca 2+ release. In contrast, we did not observe cardiac hypertrophy or pathology by increasing CASQ2 levels from 2-to 6-fold in TG hearts. This was supported by several lines of evidence, including histological data showing normal morphology and structure. In addition, expression of CASQ2 D307H did not cause an increase in SR Ca 2+ storage. These facts represent a striking difference between the CASQ2
WT and CASQ2
D307H
expression models suggesting that the mutant protein behaves very differently from the WT protein.
Biochemical studies on purified CASQ2 D307H mutant protein showed that the D307H mutation affects the Ca 2+ -dependent conformation of the protein and the ability of CASQ2 to interact with junctin and triadin [38] . An additional possibility is that the mutation may also affect the ability of CASQ2 to polymerize into long polymers that appear to be crucial to its buffering capacity [39, 40] . Our findings suggest that the expression of CASQ2 D307H destabilizes the Ca 2+ release mechanism, possibly by interfering with the CASQ2-triadin and CASQ2-junctin interactions that regulate RyR2 function [6] , leading to spontaneous, premature discharges of SR Ca 2+ stores in myocytes undergoing periodic pacing. Indeed, the membrane potential traces of TG myocytes showed delayed afterdepolarizations (DADs) and the occasional generation of action potentials at the time of spontaneous Ca 2+ transients (Fig. 5) . Increased spontaneous Ca 2+ release leads to the development of DADs through activation of depolarizing membrane currents via the Na-Ca exchange. These oscillations in membrane potential are thought to be the underlying cause of ventricular arrhythmias [20, [41] [42] [43] and would also appear to be the mechanism underlying the complex ventricular arrhythmias observed in our TG mice.
In conclusion, the findings of the present study demonstrate that over-expression of CASQ2 D307H in the mouse heart results in abnormal myocyte Ca 2+ handling and complex ventricular arrhythmias that could contribute to the CPVT phenotype observed in human patients. Our study provides important evidence to establish a link between a mutation in CASQ2 and complex ventricular arrhythmias that are consistent with the CPVT phenotype.
Limitations: a potential limitation associated with our methodology was the lack of evaluation of arrhythmias in conscious mice. However, one of the main advantages of recording ECG in anesthetized mice is the ability to record from multiple leads to improve the diagnostic specificity, which can be technically very difficult with telemetric devices in conscious and exercising mice.
